2021 TSCRS共识：转移性结直肠癌的治疗

2021-11-15 台湾结直肠外科医师学会 Front Oncol

2021年11月，台湾结直肠外科医师学会(TSCRS)发布了转移性结直肠癌的治疗共识。转移性结直肠癌（mCRC）的治疗方案近年来发生了显著变化，本文主要诊断mCRC的治疗提供共识指导。

中文标题：

英文标题：

Taiwan Society of Colon and Rectal Surgeons Consensus on mCRC Treatment

发布机构：

台湾结直肠外科医师学会

发布日期：

2021-11-15

简要介绍：

2021年11月，台湾结直肠外科医师学会(TSCRS)发布了转移性结直肠癌的治疗共识。转移性结直肠癌（mCRC）的治疗方案近年来发生了显著变化，本文主要诊断mCRC的治疗提供共识指导。内容涉及患者的选择标准、治疗目标、分子特征的治疗考虑以及最佳治疗方案的选择。

相关资料下载：

GetToolGuiderByIdResponse(projectId=1, id=0f1bd1c0022855fd, title=2021 TSCRS共识：转移性结直肠癌的治疗, enTitle=Taiwan Society of Colon and Rectal Surgeons Consensus on mCRC Treatment, guiderFrom=Front Oncol, authorId=0, author=, summary=2021年11月，台湾结直肠外科医师学会(TSCRS)发布了转移性结直肠癌的治疗共识。转移性结直肠癌（mCRC）的治疗方案近年来发生了显著变化，本文主要诊断mCRC的治疗提供共识指导。, cover=https://img.medsci.cn/2021127/1638871548575_1608702.jpg, journalId=0, articlesId=null, associationId=2208, associationName=台湾结直肠外科医师学会, associationIntro=台湾结直肠外科医师学会(TSCRS,Taiwan Society of Colon and Rectal Surgeons), copyright=0, guiderPublishedTime=Mon Nov 15 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p><span style="color: #373737;">2021年11月，台湾结直肠外科医师学会(TSCRS)发布了转移性结直肠癌的治疗共识。转移性结直肠癌（mCRC）的治疗方案近年来发生了显著变化，本文主要诊断mCRC的治疗提供共识指导。内容涉及患者的选择标准、治疗目标、分子特征的治疗考虑以及最佳治疗方案的选择。</span></p>, tagList=[TagDto(tagId=439, tagName=消化道肿瘤), TagDto(tagId=5363, tagName=转移性结直肠癌)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤, tenant=100), CategoryDto(categoryId=76, categoryName=胃肠外科, tenant=100), CategoryDto(categoryId=85, categoryName=威廉亚洲博彩公司 &解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=5363, guiderKeyword=转移性结直肠癌, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=3710, appHits=246, showAppHits=0, pcHits=296, showPcHits=3464, likes=0, shares=27, comments=10, approvalStatus=1, publishedTime=Tue Dec 07 18:10:14 CST 2021, publishedTimeString=2021-11-15, pcVisible=1, appVisible=1, editorId=1608702, editor=dajiong, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=3, createdBy=null, createdName=dajiong, createdTime=Tue Dec 07 18:05:54 CST 2021, updatedBy=1608702, updatedName=dajiong, updatedTime=Sat Jan 06 18:16:09 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2021 TSCRS共识：转移性结直肠癌的治疗.pdf)])

2021 TSCRS共识：转移性结直肠癌的治疗.pdf

下载请点击：

评论区 (8)

#插入话题

插入图片

[GetPortalCommentsPageByObjectIdResponse(id=1205270, encodeId=33c812052e027, content=有中文版吗, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6c212284887, createdName=121d314bm09暂无昵称, createdTime=Wed Mar 23 16:56:43 CST 2022, time=2022-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199683, encodeId=cd181199683fc, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2d434691732, createdName=475455347, createdTime=Sat Mar 05 16:26:03 CST 2022, time=2022-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199682, encodeId=9e7d11996823a, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2d434691732, createdName=475455347, createdTime=Sat Mar 05 16:25:30 CST 2022, time=2022-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185801, encodeId=8f041185801fe, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77156473242, createdName=ms3000001389325032, createdTime=Tue Jan 18 22:33:21 CST 2022, time=2022-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1183375, encodeId=13e111833e52b, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c1a55449782, createdName=ms7000000226096118, createdTime=Tue Jan 11 21:55:58 CST 2022, time=2022-01-11, status=1, ipAttribution=)]
2022-03-23 121d314bm09暂无昵称

有中文版吗

56 0
[GetPortalCommentsPageByObjectIdResponse(id=1205270, encodeId=33c812052e027, content=有中文版吗, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6c212284887, createdName=121d314bm09暂无昵称, createdTime=Wed Mar 23 16:56:43 CST 2022, time=2022-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199683, encodeId=cd181199683fc, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2d434691732, createdName=475455347, createdTime=Sat Mar 05 16:26:03 CST 2022, time=2022-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199682, encodeId=9e7d11996823a, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2d434691732, createdName=475455347, createdTime=Sat Mar 05 16:25:30 CST 2022, time=2022-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185801, encodeId=8f041185801fe, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77156473242, createdName=ms3000001389325032, createdTime=Tue Jan 18 22:33:21 CST 2022, time=2022-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1183375, encodeId=13e111833e52b, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c1a55449782, createdName=ms7000000226096118, createdTime=Tue Jan 11 21:55:58 CST 2022, time=2022-01-11, status=1, ipAttribution=)]
2022-03-05 475455347

很好

65 0
[GetPortalCommentsPageByObjectIdResponse(id=1205270, encodeId=33c812052e027, content=有中文版吗, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6c212284887, createdName=121d314bm09暂无昵称, createdTime=Wed Mar 23 16:56:43 CST 2022, time=2022-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199683, encodeId=cd181199683fc, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2d434691732, createdName=475455347, createdTime=Sat Mar 05 16:26:03 CST 2022, time=2022-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199682, encodeId=9e7d11996823a, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2d434691732, createdName=475455347, createdTime=Sat Mar 05 16:25:30 CST 2022, time=2022-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185801, encodeId=8f041185801fe, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77156473242, createdName=ms3000001389325032, createdTime=Tue Jan 18 22:33:21 CST 2022, time=2022-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1183375, encodeId=13e111833e52b, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c1a55449782, createdName=ms7000000226096118, createdTime=Tue Jan 11 21:55:58 CST 2022, time=2022-01-11, status=1, ipAttribution=)]
2022-03-05 475455347

学习了

75 0
[GetPortalCommentsPageByObjectIdResponse(id=1205270, encodeId=33c812052e027, content=有中文版吗, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6c212284887, createdName=121d314bm09暂无昵称, createdTime=Wed Mar 23 16:56:43 CST 2022, time=2022-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199683, encodeId=cd181199683fc, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2d434691732, createdName=475455347, createdTime=Sat Mar 05 16:26:03 CST 2022, time=2022-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199682, encodeId=9e7d11996823a, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2d434691732, createdName=475455347, createdTime=Sat Mar 05 16:25:30 CST 2022, time=2022-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185801, encodeId=8f041185801fe, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77156473242, createdName=ms3000001389325032, createdTime=Tue Jan 18 22:33:21 CST 2022, time=2022-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1183375, encodeId=13e111833e52b, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c1a55449782, createdName=ms7000000226096118, createdTime=Tue Jan 11 21:55:58 CST 2022, time=2022-01-11, status=1, ipAttribution=)]
2022-01-18 ms3000001389325032

学习学习

74 0
[GetPortalCommentsPageByObjectIdResponse(id=1205270, encodeId=33c812052e027, content=有中文版吗, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6c212284887, createdName=121d314bm09暂无昵称, createdTime=Wed Mar 23 16:56:43 CST 2022, time=2022-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199683, encodeId=cd181199683fc, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2d434691732, createdName=475455347, createdTime=Sat Mar 05 16:26:03 CST 2022, time=2022-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199682, encodeId=9e7d11996823a, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2d434691732, createdName=475455347, createdTime=Sat Mar 05 16:25:30 CST 2022, time=2022-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185801, encodeId=8f041185801fe, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77156473242, createdName=ms3000001389325032, createdTime=Tue Jan 18 22:33:21 CST 2022, time=2022-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1183375, encodeId=13e111833e52b, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c1a55449782, createdName=ms7000000226096118, createdTime=Tue Jan 11 21:55:58 CST 2022, time=2022-01-11, status=1, ipAttribution=)]
2022-01-11 ms7000000226096118

学习学习

103 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

肿瘤威廉亚洲博彩公司

2021 TSCRS共识：转移性结直肠癌的治疗

相关威廉亚洲博彩公司

拓展阅读

科室

工具

服务